Proksimal ve orta üreter taşlarında medikal ekspulsif terapi taş skoru (METSS) sisteminin dış validasyonu

Öz

Amaç: Medical Expulsive Therapy Stone Score (METSS), distal üreter taşlarında medikal ekspulsif tedavinin (MET) başarısını değerlendirmek amacıyla geliştirilmiştir. Bu çalışmada, METSS sisteminin proksimal ve orta üreter taşlarına sahip hastalarda spontan geçişi öngörme açısından dış doğrulamasını yapmayı amaçladık. Gereç ve yöntem: Eylül 2022-Haziran 2024 arasında, 4-10 mm boyutlarında proksimal veya orta üreter taşı olan 62 erişkin hastanın verileri retrospektif olarak incelendi. Hastalara günlük 4 mg silodosin içeren medikal ekspulsif tedavi (MET) uygulandı. Taş geçişi açısından hastalar 4 hafta boyunca takip edildi. METSS skorları hesaplanarak tedavi sonuçlarıyla karşılaştırıldı. Bulgular: Çalışmayı tamamlayan 54 hastanın %53,7’sinde spontan taş geçişi sağlandı. Taş boyutu, taş yükü ve METSS skorları ile tedavi başarısı arasında anlamlı ilişki bulundu. Düşük METSS skoru olan hastalarda taş geçiş oranı daha yüksekti. METSS için ROC eğrisi altında kalan alan 0,674 idi (p=0,029). METSS skoru %76 duyarlılık (sensitivite) ve %56 özgüllük (spesifite) ile orta düzeyde bir prediktif performans sergilemiştir. Sonuç: METSS skorlama sistemi, proksimal ve orta üreter taşlarının spontan geçişini öngörmede orta düzeyde prediktif güce sahiptir. Buna rağmen, konservatif ve girişimsel tedavi seçenekleri arasında karar verme sürecinde klinisyenlere rehberlik edebilir.

Anahtar Kelimeler

• Üreter taşı
• METSS
• silodosin
• skorlama sistemi
• üreterolitiyazis

External validation of the medical expulsive therapy stone score (METSS) for predicting spontaneous passage in proximal and mid-ureteral stones

Öz

Purpose: The medical expulsive therapy stone score (METSS) was developed to assess the success of MET in distal ureteral stones. In this study, we aimed to perform an external validation of the METSS to estimate spontaneous passage in patients with proximal and mid-ureteral stones. Materials and methods: We retrospectively analyzed 62 adult patients with 4-10 mm proximal or mid-ureteral stones treated with medical expulsive therapy (MET) between September 2022 and June 2024. MET consisted of silodosin (4 mg) once daily. Patients were followed weekly for up to four weeks to assess stone passage. METSS scores were calculated, and treatment outcomes were compared. Results: Spontaneous stone passage occurred in 53.7% of the 54 patients who completed the study. Stone size, stone burden, and the METSS score were significantly associated with treatment outcomes. Patients with lower METSSs had higher stone passage rates. The area under the ROC curve (AUROC) for the METSS was 0.674 (p=0.029). The METSS score demonstrated a sensitivity of 76% and specificity of 56%, indicating moderate predictive performance. Conclusion: The METSS scoring system has a moderate ability to predict the spontaneous passage of proximal and mid-ureteral stones. Nevertheless, it may assist clinicians in making informed decisions between conservative and interventional treatment strategies.

Anahtar Kelimeler

• Ureteral stone
• METSS
• silodosin
• scoring system
• ureterolithiasis

Kaynakça

1. Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, Pisani E. Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol. 2000;37(1):23-25. doi:10.1159/000020094
2. Pak CY. Kidney stones. Lancet. 1998;351(9118):1797-1801. doi:10.1016/S0140-6736(98)01295-1
3. Bahçeci T, Başer A. Comparison the efficacy of pneumatic and holmium laser ureteroscopic lithotripsy for the treatment of ureteral stones: a retrospective observational study. Pam Tıp Derg. 2022;15(4):648-655. doi:10.31362/patd.1055563
4. Aras B, Alkiş O, İvelik Hİ, Sevim M, Başer A. Holmium laser lithotripsy with semirigid ureterorenoscopy in treatment of upper ureteral and renal pelvis stones under spinal anesthesia. JCU 2020;15(3):224-228. doi:10.1177/2051415820956432
5. Liu H, Wang S, Zhu W, Lu J, Wang X, Yang W. Comparative efficacy of 22 drug interventions as medical expulsive therapy for ureteral stones: a systematic review and network meta-analysis. Urolithiasis. 2020;48(5):447-457. doi:10.1007/s00240-019-01159-5
6. Türk C, Petřík A, Sarica K, et al. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol. 2016;69(3):468-474. doi:10.1016/j.eururo.2015.07.040
7. Aghaways I, Ibrahim R, Bapir R, Salih RQ, Salih KM, Abdulla BA. The role of inflammatory serum markers and ureteral wall thickness on spontaneous passage of ureteral stone < 10 mm: a prospective cohort study. Ann Med Surg (Lond). 2022;80:104198. doi:10.1016/j.amsu.2022.104198
8. Hollingsworth JM, Canales BK, Rogers MA, et al. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ. 2016;355:i6112. doi:10.1136/bmj.i6112

9. Uzun E, Arabaci HB, Ceviz K, Koudonas A, Germiyanoglu RC, Senel S. Development of a new scoring system predicting medical expulsive therapy success on 4-10 mm distal ureteral stones: medical expulsive therapy stone score (METSS). Urolithiasis. 2023;52(1):8. doi:10.1007/s00240-023-01504-9
10. Sharma G, Pareek T, Kaundal P, et al. Comparison of efficacy of three commonly used alpha-blockers as medical expulsive therapy for distal ureter stones: A systematic review and network meta-analysis. Int Braz J Urol. 2022;48(5):742-759. doi:10.1590/S1677-5538.IBJU.2020.0548
11. Abdelaal MA, El Dydamony EM. Comparative study between Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for lower ureteral stones. Arch Ital Urol Androl. 2023;95(1):10849. doi:10.4081/aiua.2023.10849
12. Abdel Kader MS, Sayed AM, Sayed SM, AbdelRazek M. Evaluation of the efficacy and safety of either or both mirabegron and silodosin, as a medical expulsive therapy for distal ureteric stones. Int Urol Nephrol. 2024;56(5):1605-1610. doi:10.1007/s11255-023-03880-y
13. Abdullah A, Basoo Gupta Y, Selvaraj S, et al. A Comparison Between Silodosin and Tamsulosin for Medical Expulsive Therapy of Distal Ureteric Calculus. Cureus. 2023;15(10):e47008. doi:10.7759/cureus.47008
14. Faridi MS, Deshpande S. Comparing silodosin and mirabegron as medical expulsive therapy for distal ureteral calculus: a prospective, randomized study. Cent European J Urol. 2024;77(2):286-290. doi:10.5173/ceju.2023.182
15. Selvi I, Baydilli N, Tokmak TT, Akinsal EC, Basar H. CT-related parameters and Framingham score as predictors of spontaneous passage of ureteral stones ≤ 10 mm: results from a prospective, observational, multicenter study. Urolithiasis. 2021;49(3):227-237. doi:10.1007/s00240-020-01214-6
16. Khan RU, Nazim SM, Anwar S. CT-Based Predictors of Spontaneous Ureteral Stone Passage. J Coll Physicians Surg Pak. 2024;34(8):879-884. doi:10.29271/jcpsp.2024.08.879
17. Shah TT, Gao C, Peters M, et al. Factors associated with spontaneous stone passage in a contemporary cohort of patients presenting with acute ureteric colic: results from the Multicenter cohort study evaluating the role of Inflammatory Markers In patients presenting with acute ureteric Colic (MIMIC) study. BJU Int. 2019;124(3):504-513. doi:10.1111/bju.14777
18. Ibrahim AK, Mahmood IH, Mahmood NS. Efficacy and safety of tamsulosin vs. alfuzosin as medical expulsive therapy for ureteric stones. Arab J Urol. 2013;11(2):142-147. doi:10.1016/j.aju.2013.02.003
19. Çelik S, Akdeniz F, Afsar Yildirim M, et al. Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones. Arch Ital Urol Androl. 2018;90(2):117-122. doi:10.4081/aiua.2018.2.117
20. Moon YJ, Kim HW, Kim JB, Kim HJ, Chang YS. Distribution of ureteral stones and factors affecting their location and expulsion in patients with renal colic. Korean J Urol. 2015;56(10):717-721. doi:10.4111/kju.2015.56.10.717
21. Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol. 2007;14(8):749-753. doi:10.1111/j.1442-2042.2007.01812.x
22. Ramasamy V, Aarthy P, Sharma V, Thakur APS. Role of inflammatory markers and their trends in predicting the outcome of medical expulsive therapy for distal ureteric calculus. Urol Ann. 2022;14(1):8-14. doi:10.4103/ua.ua_139_21
23. Gao C, Peters M, Kurver P, et al. BURST Collaborative MIMIC Study Group. Nomogram predicting the probability of spontaneous stone passage in patients presenting with acute ureteric colic. BJU Int. 2022;130(6):823-831. doi:10.1111/bju.15839